Literature DB >> 18462103

Secondary syphilis with ocular manifestations in older adults.

Ryan C Maves1, Edward R Cachay, Maile Ann Young, Joshua Fierer.   

Abstract

We describe 4 patients (age, >50 years) with secondary syphilis. All patients presented with ocular syphilis, and 2 presented with syphilis-negative rapid plasma reagin titers due to a prozone phenomenon. Three male patients reported sildenafil use. The presentation of these patients with ocular syphilis suggests the need for additional clinical studies involving older patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18462103     DOI: 10.1086/588483

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  5 in total

1.  Bilateral ocular perineuritis as the presenting feature of acute syphilis infection.

Authors:  K O'Connell; M Marnane; C McGuigan
Journal:  J Neurol       Date:  2011-07-06       Impact factor: 4.849

2.  A case of secondary syphilis presenting as optic neuritis.

Authors:  Monica Bandettini di Poggio; Alberto Primavera; Elisabetta Capello; Fabio Bandini; Giovanni Mazzarello; Claudio Viscoli; Angelo Schenone
Journal:  Neurol Sci       Date:  2010-02-25       Impact factor: 3.307

3.  Ocular syphilis among HIV-infected individuals.

Authors:  Jonathan Z Li; Joseph D Tucker; Ann-Marie Lobo; Christina M Marra; Benjamin T Davis; George N Papaliodis; Donna Felsenstein; Marlene L Durand; Sigal Yawetz; Gregory K Robbins
Journal:  Clin Infect Dis       Date:  2010-08-15       Impact factor: 9.079

Review 4.  Ocular syphilis among HIV-infected patients: a systematic analysis of the literature.

Authors:  Joseph D Tucker; Jonathan Z Li; Gregory K Robbins; Benjamin T Davis; Ann-Marie Lobo; Jan Kunkel; George N Papaliodis; Marlene L Durand; Donna Felsenstein
Journal:  Sex Transm Infect       Date:  2010-08-26       Impact factor: 3.519

Review 5.  Ocular Syphilis: a Clinical Review.

Authors:  Sophie L Woolston; Shireesha Dhanireddy; Jeanne Marrazzo
Journal:  Curr Infect Dis Rep       Date:  2016-11       Impact factor: 3.663

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.